Effective sample size for computing prior hyperparameters in Bayesian phase I–II dose-finding

Abstract

The two key improvements greatly enhance the efficacy-toxicity design's practical usefulness and are straightforward to implement using the updated computer program. The algorithm for determining prior hyperparameters to ensure a specified level of informativeness is general, and may be applied to models other than that underlying the efficacy-toxicity method.